Jackson Hole Capital Partners LLC Has $3.05 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Jackson Hole Capital Partners LLC trimmed its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 10.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,717 shares of the company's stock after selling 2,168 shares during the period. Jackson Hole Capital Partners LLC's holdings in Zoetis were worth $3,050,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. State Street Corp lifted its stake in Zoetis by 0.5% in the third quarter. State Street Corp now owns 19,779,344 shares of the company's stock valued at $3,864,488,000 after acquiring an additional 95,856 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Zoetis by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 10,427,760 shares of the company's stock worth $2,030,813,000 after purchasing an additional 185,364 shares during the period. Bank of New York Mellon Corp raised its holdings in Zoetis by 8.5% in the 4th quarter. Bank of New York Mellon Corp now owns 5,561,910 shares of the company's stock valued at $906,202,000 after acquiring an additional 433,429 shares in the last quarter. Mizuho Securities USA LLC raised its stake in shares of Zoetis by 13,726.9% in the third quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company's stock valued at $950,524,000 after purchasing an additional 4,829,815 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Zoetis by 5.3% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,896,106 shares of the company's stock worth $761,221,000 after acquiring an additional 194,542 shares during the period. Institutional investors and hedge funds own 92.80% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Barclays increased their price objective on Zoetis from $242.00 to $244.00 and gave the stock an "overweight" rating in a research note on Friday, February 14th. UBS Group assumed coverage on shares of Zoetis in a report on Monday, December 9th. They issued a "neutral" rating and a $196.00 price target for the company. Stifel Nicolaus dropped their target price on Zoetis from $210.00 to $180.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Piper Sandler raised their price target on Zoetis from $200.00 to $205.00 and gave the company an "overweight" rating in a report on Thursday, February 27th. Finally, Morgan Stanley dropped their price objective on Zoetis from $243.00 to $238.00 and set an "overweight" rating for the company in a report on Friday, February 14th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and an average target price of $215.90.

Zoetis Trading Down 1.0 %

NYSE:ZTS traded down $1.65 during trading hours on Thursday, hitting $160.03. The stock had a trading volume of 2,744,683 shares, compared to its average volume of 2,573,720. The business's 50 day moving average is $166.92 and its 200-day moving average is $176.44. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75. The company has a market cap of $71.66 billion, a price-to-earnings ratio of 29.26, a P/E/G ratio of 2.78 and a beta of 0.94. Zoetis Inc. has a one year low of $144.80 and a one year high of $200.33.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. The business had revenue of $2.32 billion for the quarter, compared to the consensus estimate of $2.30 billion. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. Sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date is Monday, April 21st. Zoetis's dividend payout ratio (DPR) is presently 36.56%.

Insider Transactions at Zoetis

In related news, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $170.00, for a total transaction of $55,420.00. Following the completion of the sale, the executive vice president now owns 15,781 shares of the company's stock, valued at approximately $2,682,770. The trade was a 2.02 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Willie M. Reed sold 1,210 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $166.14, for a total value of $201,029.40. Following the transaction, the director now owns 11,245 shares in the company, valued at $1,868,244.30. The trade was a 9.71 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,862 shares of company stock worth $312,254 in the last ninety days. Insiders own 0.16% of the company's stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.